首页> 美国卫生研究院文献>Journal of Medical Case Reports >Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
【2h】

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report

机译:Pro24Ser转甲状腺素蛋白突变相关的遗传性心脏淀粉样变性:病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundTransthyretin amyloidosis is a systemic disorder caused by extracellular deposition of insoluble amyloid fibrils in peripheral and autonomic nerves, heart, kidney, gastrointestinal tract, and other organs. Hereditary transthyretin amyloidosis is an autosomal dominant disease. More than 120 mutations have been reported in the transthyretin gene with considerable phenotypic heterogeneity and geographic diversity. Among them, a sporadic case of hereditary transthyretin amyloidosis with cardiac-predominant phenotype is very rare, progressive, and potentially fatal if left undiagnosed. However, a clinical diagnosis of cardiac amyloidosis still remains challenging due to non-specific symptoms, and less sensitivity and specificity of medical examinations.
机译:背景运甲状腺素蛋白淀粉样变性病是由外周和自主神经,心脏,肾脏,胃肠道和其他器官中的不溶性淀粉样蛋白原纤维的细胞外沉积引起的系统性疾病。遗传性运甲状腺素蛋白淀粉样变性是常染色体显性疾病。据报道,转甲状腺素蛋白基因中有120多个突变,具有明显的表型异质性和地理多样性。其中,以心脏为主的表型的遗传性甲状腺素转运蛋白淀粉样变性的零星病例非常少见,进行性,如果不加以诊断可能致命。然而,由于非特异性症状以及医学检查的敏感性和特异性较低,心脏淀粉样变性的临床诊断仍然具有挑战性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号